Looking forward to Aug/Sep, I think. I doubt we'll see much in the way of news in April, unless IIL have already started collating results and feel the need to update the market?!
Given that the bulk of patients will have already completed their trials, would anyone at IIL already be aware of how the initial patients fared? Or is it all just put in a black box until the final patient completes their course so nobody is any the wiser until all data is in?
Looking forward to Aug/Sep, I think. I doubt we'll see much in...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
